Email: info@neweastbio.com   |  Call: 6109452007

CTC-BIOPSY®-A10

Automatic FISH Slide Processing System

Previous slide
Next slide

FISH-F901


To Capture and Enrich:
Circulating Tumor Cell (CTC) and Circulating Tumor Microemboli (CTM) from whole blood with Nano-sieve for further clinical research

Cat. #: FI-F901

Automation
Automatic sample pretreatment and cleaning steps.
High Throughput
Up to 24 samples can be pretreated and cleaned simultaneously.
Excellent Performance
High temperature control precision, small temperature fluctuation, fast rising and cooling
speed, magnetic stirring technology, high background contrast after sample processing.
Flexible Operation
Users can design the experimental process and experimental steps by themselves, support a variety of reagents, up to 12 reagents, up to 12 reagents input, convenient maintenance, fault judgment function to make equipment safer operation.
Small & Portable
Compact, high equipment intergration, saving space.

Specification

Optimized isolation technology by size of epithelial tumor cells (ISET) can accurately and reliably capture abnormal cells in blood, providing a efficient solution for tumor screening.

■ High-risk Tumor screening
■ Companion Diagnosis   ■ Early Warning
CTC-BIOPSY® Captures CTC
CTC-BIOPSY® Captures CTM

Patented ISET Technology

ISET technology uses the size and deformability of tumor cells to achieve separation, then use cell morphology for identification.

With good light transmission, second-generation nano polymer material is resistance to various staining reagents, allowing direct observation of cells in visible light.
Nano-microsieve technology broke the foreign monoply, high-precision lithography machine for laser lithography.
13mm micro sieve membrane has 160,000 nano micro sieves with an aperture of 8um to maximize the sorting of blood cells and tumor cell enrichment.

High Detection Rate of CTM

CTC detection data of the CTC-BIOPSY® system in 2018-2020 showed an average CTC detection rate for each tumor is 80.90% ,CTM (Circulating Tumor Microemboli) detection rate is 12.52%, and the ratio of CTM to total CTC detection was consistent with study data from Nature in 2019.

Partial Detection Data of CTC and CTM from 2018 to 2020:

Accurate Classification of CTM

CTC neutrophil clusters, representing a critical weakness in the metastatic process, the link between neutrophils and CTC drives the progress of cell cycle in the blood flow and expands the metastatic potential of CTC.

CTCBIOPSY® is the only NMPA approved detection system in China, it can efficiently capture CTMs containing neutrophils, which can be seen directly with eye under ordinary optical microscopes. Patients with higher risk of metastasis can be accurately screened for clinical diagnosis and treatment.

CTCBIOPSY®Systematically Detect CTM Containing Neutrophils:

 

 

Fast FISH Leader

Convenient · Efficient · Safe

FISH-F901